Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer Grant Program
- Deadline
- July 15, 2026
- Funding
- Up to $250,000
- Geography
- National
- Posted
- June 6, 2026
Grant Overview
Pfizer’s Competitive Grants Program supports independent initiatives including research, quality improvement, and education to improve patient outcomes in areas of unmet medical need aligned with Pfizer’s medical and scientific strategies. The program operates through publicly posted Requests for Proposal (RFP) that outline specific areas of interest and review timelines. Organizations submit applications addressing identified gaps in research, practice, or care as detailed in specific RFPs….